Clinicopathologic and prognostic implications of progranulin in breast carcinoma

Chinese Medical Journal

Volumn 124, Issue 13, 2011, Pages 2045-2050

  Li, Li Qin ^a   Huang, Hui Lian ^a   Ping, Jin Liang ^a   Wang, Xiao Hong ^a   Zhong, Jing ^a   Dai, Li Cheng ^a  

^a HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Angiogenesis; Breast carcinoma; Endoglin; Immunohistochemistry; Progranulin

Indexed keywords

ENDOGLIN; PROGRANULIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ANTIGENS, CD; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960063719     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.13.022     Document Type: Article

References (27)

1. Serrero G. Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun 2003; 308: 409-413.
2. Tangkeangsirisin W, Serrero G. PC cell-derived growth factor (Progranulin/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 2004; 25: 1587-1592.
3. Serrero G, Ioffe OB. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Hum Pathol 2003; 34: 1148-1154.
4. Chen XY, Li JS, Liang QP, He DZ, Zhao J. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance. Chin Med J 2008; 121: 881-886.
5. Halper J, Moses HL. Purification and characterization of a novel transforming growth factor. Cancer Res 1987; 47: 4552-4559.
6. Shoyab M, McDonald VL, Byles C, Todaro GJ, Plowman GD. Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proc Natl Acad Sci USA 1990; 87: 7912-7916.
7. Halper J. Growth factors as active participants in carcinogenesis: A perspective. Vet Pathol 2010; 47: 77-97.
8. Devoogdt N, Rasool N, Hoskins E, Simpkins F, Tchabo N, Kohn EC. Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo. Cancer Sci 2009; 100: 434-440.
9. Cuevas-Antonio R, Cancino C, Arechavaleta-Velasco F, Andrade A, Barron L, Estrada I, et al. Expression of progranuliln (acrogranin/ Progranulin/ granulin-epithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line. Cancer Invest 2010; 28: 452-458.
10. Liu Y, Xi L, Liao G, Wang W, Tian X, Wang B, et al. Inhibition of PC cell-derived growth factor (Progranulin)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2. BMC Cancer 2007; 7: 22-31.
11. Simpkins F, Devoogd N, Rasool N, Tchabol N, Alejandrol E, Kamraval M, et al. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells. Carcinogenesis 2008; 29: 466-472.
12. Pizarro GO, Zhou XC, Koch A, Gharib M, Raval S, Bible K, et al. Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse. Int J Cancer 2007; 120: 2339-2343.
13. Donald CD, Laddu A, Chandham P, Lim SD, Cohen C, Amin M, et al. Expression of progranuliln and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium. Anticancer Res 2001; 21: 3739-3742.
14. Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, et al. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology 2008; 47: 1524-1532.
15. Wang W, Hayashi J, Serrero G. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Clin Cancer Res 2006; 12: 49-56.
16. Monami G, Emiliozzi V, Bitto A, Lovat F, Xu SQ, Goldoni S, et al. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol 2009; 174: 1037-1047.
17. Jones MB, Houwink AP, Freeman BK, Greenwood TM, Lafky JM, Lingle WL, et al. The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer. J Soc Gynecol Investig 2006; 13: 304-311.
18. Monami G, Gonzalez EM, Hellman M, Gomella LG, Baffa R, Lozzo RV, et al. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer Res 2006; 66: 7103-7110.
19. Stewart DJ. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol 2010; 75: 173-234.
20. Hu Y, Lin DM, Cheng SJ, Liu YN, Feng FY. Influences of PC cell-derived growth factor and breast cancer resistance protein on the curative effects of platinum-based chemotherapeutic regimens for advanced non-small cell lung cancer. Natl Med J China (Chin) 2006; 86: 2611-2614.
21. Jones MB, Spooner M, Kohn EC. The granulin-epithelin precursor: a putative new growth factor for ovarian cancer. Gynecol Oncol 2003; 88 (1 Pt 2): S136-S139.
22. He Z, Ismail A, Kriazhev L, Sadvakassova G, Bateman A. Progranuliln (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res 2002; 62: 5590-5596.
23. He Z, Bateman A. title typecontributorProgranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 2003; 81: 600-612.
24. Huang T, Song HP, Zhang JH. Human breast carcinoma cell line MCF-7 and expression of VEGF. Cancer (Chin) 2006; 25: 303-307.
25. Desmarais JA, Cao MJ, Bateman A, Murphy BD. Spatiotemporal expression pattern of progranuliln in embryo implantation and placenta formation suggests a role in cell proliferation, remodeling, and angiogenesis. Reproduction 2008; 136: 247-257.
26. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002; 2: 795-803.
27. Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ, et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008; 14: 1931-1937.